Article

Low-vision rehab to get coverage during project

Washington, DC?The Centers for Medicare and Medicaid Services (CMS) will expand its coverage of vision rehabilitation services in a 5-year demonstration project scheduled to start this month.

Washington, DC-The Centers for Medicare and Medicaid Services (CMS) will expand its coverage of vision rehabilitation services in a 5-year demonstration project scheduled to start this month.

The project, sponsored by Sen. John Sununu (R-NH), will take place in six areas: Atlanta, Kansas, New Hampshire, New York City, North Carolina, and Washington state.

The goal is to provide CMS with information on the feasibility of standardized national Medicare coverage of vision rehabilitation by an expanded group of authorized providers. Although Medicare currently covers these services when provided by certain Medicare-qualified therapists, the project will include coverage for services by certified low-vision therapists, orientation and mobility specialists, rehabilitation teachers, and occupational therapists. Under the plan, the supervising physician will no longer have to be on the premises during therapy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.